
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions ā written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Tricuspid regurgitation stages
Introduction
Overview
Overview
The stage of tricuspid regurgitation (TR) can be estimated based on specific criteria for the valve anatomy, valve hemodynamics, associated cardiac findings, and symptoms. The stages of TR are the following: at risk of TR, progressive TR, asymptomatic severe TR, and symptomatic severe TR.[1]
Stages
Stages
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[2]
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[2]
Stages of TR
| Stage | Definition | Valve hemodynamics | Hemodynamic consequences | Clinical Symptoms and Presentation |
|---|---|---|---|---|
| B | Progressive TR |
|
None | None |
| C | Asymptomatic severe TR |
|
|
|
| D | Symptomatic severe TR | Central jet ā„50% RA
Vena contracta width ā„0.7 cm ERO ā„0.40 cm2Regurgitant volume ā„45 mL Dense continuous wave signal with triangular shape Hepatic vein systolic flow reversal |
|
|
Shown below is a table depicting the stages of TR adapted from the 2014 AHA/ACC guidelines for management of valvular heart disease.[1]
Abbreviations: CW: continuous wave; ICD: implantable cardioverter-defibrillator; IE: infective endocarditis; IVC: inferior vena cava; RA: right atrium; RV: right ventricle; TR: tricuspid regurgitation
| Stage | Definition | Valve anatomy | Valve hemodynamics | Hemodynamic consequences | Symptoms of TR, left heart failure, or pulmonary vascular disease |
|---|---|---|---|---|---|
| A | At risk of TR | Primary
Secondary
|
Absent or trace TR | Absent | Absent |
| B | Progressive TR | Primary
Secondary
|
Mild TR
Moderate TR
|
Mild TR
Moderate TR |
Absent |
| C | Asymptomatic severe TR | Primary
Secondary
|
* Central jet area >10.0 cm
2* Vena contracta width >0.7 cm
|
* Dilated RV/RA/IVC and decreased IVC respirophasic variation | Absent |
| D | Symptomatic severe TR | Primary
Secondary
|
* Central jet area >10.0 cm2
|
* Dilated RV/RA/IVC and decreased IVC respirophasic variation
|
Presence of symptoms (fatigue, dyspnea, anorexia, edema, abdominal distention, palpitations) |
References
References
- ā 1.0 1.1 Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). “2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines”. Circulation. doi:10.1161/CIR.0000000000000029. PMIDĀ 24589852.
- ā Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F; et al. (2021). “2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines”. Circulation. 143 (5): e72āe227. doi:10.1161/CIR.0000000000000923. PMIDĀ 33332150 Check
|pmid=value (help).
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
